By Mark Speers, Contributor
Published in the April 20, 2017 Issue (Vol. 4, No. 6)
At the recent MassMEDIC MedTech Investors Conference, Mark Speers, Co-Founder and Managing Director of Health Advances, interviewed John McDonough, CEO of medical diagnostics company T2 Biosystems, on the topic of capital fundraising.
T2 Biosystems Inc.